SEC Form 4 · accession 0001209191-15-048545
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anton Gueth
Director
Period of report
May 28, 2015
Accepted (ET)
Jun 1, 2015 · 8:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy)F1,F3,F2 | $2.18 | May 28, 2015 | A | 99,395 | A | — | May 27, 2025 | Common Stock | 99,395 | 99,395 | D |
Explanation of responses
- F1Represents grant of options to purchase shares of common stock, par value of $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- F2The options vest in equal quarterly installments over one year.
- F3Not applicable